Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-12-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000983 |
| _version_ | 1797281207189241856 |
|---|---|
| author | Sathej Gopalakrishnan Rajeev Menon Ahmed A. Suleiman Arnon P. Kater Stephan Stilgenbauer John F. Seymour Brenda Chyla Tong Lu Su Young Kim Andrew W. Roberts Jennifer A. Woyach Sven Mensing Ahmed Hamed Salem |
| author_facet | Sathej Gopalakrishnan Rajeev Menon Ahmed A. Suleiman Arnon P. Kater Stephan Stilgenbauer John F. Seymour Brenda Chyla Tong Lu Su Young Kim Andrew W. Roberts Jennifer A. Woyach Sven Mensing Ahmed Hamed Salem |
| author_sort | Sathej Gopalakrishnan |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:53:15Z |
| format | Article |
| id | doaj.art-a2f017128b0e46e6a3b38e44b5b505e7 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:53:15Z |
| publishDate | 2023-12-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-a2f017128b0e46e6a3b38e44b5b505e72024-03-03T04:31:45ZengWileyHemaSphere2572-92412023-12-01712e98310.1097/HS9.0000000000000983202312000-00003Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical StudiesSathej Gopalakrishnan0Rajeev Menon1Ahmed A. Suleiman2Arnon P. Kater3Stephan Stilgenbauer4John F. Seymour5Brenda Chyla6Tong Lu7Su Young Kim8Andrew W. Roberts9Jennifer A. Woyach10Sven Mensing11Ahmed Hamed Salem121 Clinical Pharmacology, AbbVie, Ludwigshafen, Germany2 Clinical Pharmacology, AbbVie, North Chicago, IL, USA1 Clinical Pharmacology, AbbVie, Ludwigshafen, Germany3 Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, on behalf of HOVON CLL WG, Amsterdam, The Netherlands4 Division of CLL, Department III of Internal Medicine, Ulm University, Ulm, Germany5 Department of Hematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, University of Melbourne, Parkville, VIC, Australia6 Precision Medicine Oncology, AbbVie, North Chicago, IL, USA7 Genentech Inc, South San Francisco, CA, USA8 Oncology Development, AbbVie, North Chicago, IL, USA5 Department of Hematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, University of Melbourne, Parkville, VIC, Australia9 Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA1 Clinical Pharmacology, AbbVie, Ludwigshafen, Germany2 Clinical Pharmacology, AbbVie, North Chicago, IL, USAhttp://journals.lww.com/10.1097/HS9.0000000000000983 |
| spellingShingle | Sathej Gopalakrishnan Rajeev Menon Ahmed A. Suleiman Arnon P. Kater Stephan Stilgenbauer John F. Seymour Brenda Chyla Tong Lu Su Young Kim Andrew W. Roberts Jennifer A. Woyach Sven Mensing Ahmed Hamed Salem Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies HemaSphere |
| title | Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies |
| title_full | Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies |
| title_fullStr | Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies |
| title_full_unstemmed | Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies |
| title_short | Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies |
| title_sort | relationship between venetoclax exposure and undetectable minimal residual disease rates in relapsed refractory patients with chronic lymphocytic leukemia a pooled analysis of six clinical studies |
| url | http://journals.lww.com/10.1097/HS9.0000000000000983 |
| work_keys_str_mv | AT sathejgopalakrishnan relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT rajeevmenon relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT ahmedasuleiman relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT arnonpkater relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT stephanstilgenbauer relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT johnfseymour relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT brendachyla relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT tonglu relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT suyoungkim relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT andrewwroberts relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT jenniferawoyach relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT svenmensing relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT ahmedhamedsalem relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies |